HOME JOURNALS CONTACT

Pharmacologia

Year: 2013 | Volume: 4 | Issue: 6 | Page No.: 457-463
DOI: 10.17311/pharmacologia.2013.457.463
Boswellia serrata-frankincense (A Jesus Gifted Herb); An Updated Pharmacological Profile
Navdeep Bansal, Sidharth Mehan, Sanjeev Kalra and Deepa Khanna

Abstract: Traditionally, herbal plants are widely and frequently used as medicines for curing and anticipating of various diseases and ailments. Plants belonging to family Burseraceae are very important and widely used as therapeutic agents. From ancient times, Boswellia serrata (BS), belonging to family Burseraceae is well known as frankincense (Jesus gifted herb). Resins are main constituents of Burseraceae family, β-boswellic acid, acteyl-β-boswellic acid, 11-keto-β-boswellic acid, acetyl-11-keto-β-boswellic acid, α-boswellic acid, acetyl-α-boswellic acid are few among several medicinally important constituents of BS generally used for curing various ailments such as rheumatism, skin diseases, cough, diarrhea, constipation, flatulence, stomachic, carminative, diuretic and neurodegenerative. Bench work has revealed numerous pharmacological activities of BS viz., anti-inflammatory, anti-oxidant, anti-ulcer, anti-arthritic, anti-asthmatic, anti-artherosclerotic, anti-cancer, anti-diarrhoeal, hepatoprotective, anti-microbial, anti-hyperglycemic, wound healing, diuretic and analgesic. However, few activities like wound healing, hypoglycemic property need intense and focused research for confirmed results. In this review, we have widely discussed chemical constituents and medicinal potential of BS.

Fulltext PDF Fulltext HTML

How to cite this article
Navdeep Bansal, Sidharth Mehan, Sanjeev Kalra and Deepa Khanna, 2013. Boswellia serrata-frankincense (A Jesus Gifted Herb); An Updated Pharmacological Profile. Pharmacologia, 4: 457-463.

Keywords: anti-arthritic, anti-inflammatory, Boswellia serrata and anti cancer

INTRODUCTION

Historically plants have been placed at top among the sources of novel drugs. As traditional medicines based on plants and plant extracts have made considerable contributions to human health and well-being. The medicinal plants are widely used by the traditional medicinal practitioners for curing and prevention of various diseases in their day to day practice. Among the plants known for medicinal value, the plants of family Burseraceae are very important for their therapeutic potential. Burseraceae is represented in plant kingdom with 17 genera and 600 species, where species of this family produce commercially valuable resin as raw material1. Frankincense, also known as olibanum, is the resin obtained from the trees of the Boswellia, native to Arabia and India. Frank (“pure”) incense was the finest and scarcest, produced only in a small area of the Arabian Peninsula, Somalia and Ethiopia. The word frankincense derived from the old French word frank-encens means the true, authentic, pure, or “free lighting” incense. The word olibanum derived from the Arabic al-luban means the milk or authentic incense. Ancient civilizations used incense in their rituals and prayers to god Hindus, Babylonians, Assyrians, Persians, Romans, Chinese and Greeks burned these resins as they believe that burning Boswellia resins during scarification ceremonies or in their daily rituals prevent the influence of bad spirits and also please their Gods on their souls1. Gajabhakshya suggests that since antiquity Boswellia species was found to be one of ingredient of elephant’s diet2.

The resin is popularly used in Indian Systems of Medicine (Unani, Ayurvedic and Sidha) for the last several centuries in curing various ailments especially rheumatism, skin diseases, cough, diarrhoea, constipation, flatulence, stomachic, carminative, diuretic, central nervous diseases and others. Beyond that, there are medical evidences that frankincense was important for wound healing, dysentery, dyspepsia, lung diseases, hemorrhoids, urinary disorders and corneal ulcers3. It has made important contribution to the field of science from ancient times to modern research due to its large number of medicinal effects like anti-inflammatory4, anti-oxidant5, anti-ulcer6, anti-arthritic7, anti-asthmatic8, anti-artherosclerotic9, anti-cancer10, anti-diarrhoeal11, hepatoprotective12, anti-microbial13, anti-hyperglycemic14, wound healing15, diuretic16 and analgesic17. In light of above an attempt has been made to review the pharmacognostical and pharmacological aspects of BS.

DESCRIPTION

BS is a moderate to large sized, branching and deciduous tree of genus Boswellia with thin, greenish grey, yellow or reddish and finally turning to ash colored papery bark (Table 1).

The leaves are alternate, imparipinnate, 30-45 cm long, ex-stipulate and crowded at the end of the branches. The flowers are bisexual, small and white in axillary racemes or panicles at the tip of the branches. BS tree, on injury, exudates an oleo-gum-resin known as Salai Guggal, Indian Frankincense or Kundur (Table 2).

It is fragrant, transparent, golden yellow and after solidification it turns into brownish yellow tears or drops and crusts. Oleo-gum-resin mainly contains oils, terpenoids and gums (Table 3)18.




PHARMACOLOGICAL ACTIVITIES

Anti-inflammatory activity: Boswellic acids are specific non-redox inhibitors of leukotrienes interacting directly with 5-lipoxygenase (5-LOX) including inflammatory mediators such as 5-hydroxyeicosatetraenoic acid (5-HETE) and leukotriene B4 (LTB-4) in various animal models, ultimately leads to bronchoconstriction, chemotaxis and increased vascular permeability21. Methanolic extract of BS exhibits anti-inflammatory property by inhibiting cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-1beta (IL-1β), nitric oxide and mitogen activated protein kinases (MAPK) in human peripheral blood mononuclesar cells and in mouse macrophages4. Boswellic acid extracts, boswellic acid and its biologically active pentacyclic triterpenes block leukotriene biosynthesis and exerts anti-inflammatory effect3.

Anti-oxidant activity: Essential oils (monoterpenes, sesquiterpenes and phenolic compounds) from BS can be an important source of natural anti-oxidants. Various findings have indicated that these essential oils might be helpful in preventing the progression of many diseases induced by oxidative stress5. In-vitro study on methanolic and aqueous extract of BS has revealed that it contains high amount of total flavanoids and total phenolics compound significantly inhibit the nitrite formation, superoxide free radical generation, scavenge DPPH and spare glutathione22.

Anti-ulcer activity: The petroleum ether and aqueous extracts of BS at the dose of 250 mg kg-1 significantly show anti-ulcer activity, as indicated by the reduction of ulcer index in peptic ulcer rats23. Evaluation of anti-ulcer activity of boswellic acids in universally accepted animal models viz., pyloric ligation, ethanol/HCl, acetyl salicylic acid, indomethacin and cold restrained stress-induced ulceration in rats revealed that boswellic acids possess a dose dependent antiulcer activity exhibiting different degree of inhibition of the ulcer score towards different ulcerogenic agents6 (Fig. 1).

Anti-arthritic activity: The gum resin of BS normally contains boswellic acids which helps to preserve the structural of joint cartilage and maintain a healthy immune mediator cascade at a cellular level. Boswellic acids are active against pain and inflammation by inhibiting leukotriene synthesis7. BS inhibit the enzymatic activity of 5-lipoxgenase (5-LOX), an inflammation marker in osteoarthritis24,25 (Fig. 1). Oral and intraperitoneally, administrated BS extract inhibited carrageenan-induced rat hind paw oedema by 39.75% and 65-73%, respectively.

Anti-arthritic studies of BS show effective results in both adjuvant and established arthritis. 5-Loxin, a novel BS extract enriched with AKBA, exert its beneficial anti-inflammatory effect by reducing proinflammatory cytokine mediators. 5-Loxin potentially improves pain, joint stiffness and physical function in osteoarthritis patients26. Another experimental study demonstrate that BS extract at the dose of 333 mg/capsule reduce the pain in the affected knee joints, decrease swelling and improve knee flexion, stairs climbing and walking distance in patients of osteoarthritis of knee7. BS extract has been claimed to decrease the glycosaminoglycan degradation which helps to keep the cartilage in good condition which might be responsible for the recovery of the patients in Osteoarthritis and stops the progression of this condition27. BS extract has an effect on production of antibodies and cell-mediated immunity and inhibits human leukocyte elastase (HLE), a marker of several diseases including rheumatoid arthritis3 (Fig. 1). Thus, BS significantly improved patient’s mobility.

Anti-asthmatic activity: In asthma, increased level of leukotrienes and various inflammatory mediators results in bronchoconstriction. BS extract exhibit a potential therapy for asthma as it has been evidenced from the results of studies that ethanolic extract of BS inhibited 5-lipoxygenase (5-LOX), an enzyme responsible for the synthesis of leukotrienes28. Clinical trial conducted by Gupta et al, (1998) on males and females in the age range of 18-75 years having dyspnoea, number of attacks, increase in forced expiratory volume, subset1, forced vital capacity and peak expiratory flow rate as well as decrease in eosinophilic count and erythrocyte sedimentation rate, symptoms of bronchial asthma significantly showed improvement of disease as evident by disappearance of these physical symptoms and signs when treated with a preparation of gum resin8. Furthermore, BS extract also significantly decrease the levels of leukotriene-C4 (LT-C4), nitric oxide (NO) and malondialdehyde (MDA) in plasma of 63 bronchial asthmatic patients29. In preclinical studies BS extract containing AKBA and with other active constituents like KBA, acetyl beta-boswellic acid and beta-boswellic acid showed anti-anaphylactic and mast cell stabilizing activity30.

Anti-atherosclerotic activity: It has also been reported that aqueous and hydroalcoholic extracts of BS gum resin exhibits anti-thrombotic, anti-oxidant, anti-platelet and anti-coagulant activities which are beneficial in the prevention of thrombus formation and coronary atherosclerosis31. An in-vivo and in vitro study on hypocholesterolemic activity revealed that water-soluble fraction of the oleo-gum-resin of BS extract inhibits the lipopolysaccharide-induced nitric oxide (NO) production and an increase in serum HDL level in rat macrophages9.

Anticancer activity: Triterpenic acids of BS including beta-boswellic acid, 3-O-acetyl-beta-boswellic acid 11-keto-beta-boswellic acid (KBA) and 3-O-acetyl-11-keto-beta-boswellic acid (AKBA) in a dose dependent manner demonstrate in-vitro anti-carcinogenic effects by inhibiting the DNA, RNA and protein synthesis in human leukemia HL-60 cells. Among all, AKBA was the significant inhibition of cellular growth of HL-60 cells without affecting cell viability32. Triterpenediol (TPD) of boswellic acid constituting isomeric mixture of 3-α, 24-dihydroxyurs-12-ene and 3-α, 24-dihydroxyolean-12-ene exhibited potential apoptotic activity against cancer cells of human leukemia HL-60. Authors hypothesized that induction of oxidative stress in tumor cells and regulated activation of both intrinsic and extrinsic signaling pathways by ROS and NO may elicit cell death mechanisms by TPD33 (Fig. 1). Further, it has also been evidenced that the ethanolic extract of BS gum resin containing a defined amount of boswellic acids exhibit potent anti-proliferative effect on five leukemia (HL-60, K562, U937, MOLT-4, THP-1) and two brain tumor (LN-18, LN-229) cell lines34. Moreover, it has been demonstrated that AKBA inhibit the phosphorylation of extracellular signal-regulated kinase 1 and 2 (Erk-1 and Erk-2) in meningioma cells and might be involved in the suppression of proliferation and apoptosis related tumor on the basis of above concerned mechanisms35. Pentacyclic TPD in human cervical cancer HeLa and SiHa cells by suppressing the expression of PI3K/pAkt, ERK1/2 and NF-kappaB/Akt in various signaling cascades effectively coordinates the survival of cancer cells36.

Shah et al.37 also highlight the fact that analogues prepared from β-boswellic acid and 11-keto-β-boswellic acid improved cytotoxic and apoptotic activity by inducing DNA fragmentation through various replacement reactions. Researchers have evaluated the efficacy of AKBA as a chemo protective agent against intestinal adenomatous polyposis coli multiple intestinal neoplasia [APC(Min/+)] mouse model. AKBA treatment reduces the numbers and size of colonic polyposis as well as number of dysplastic cells38. AKBA has also been found to be involved in the inhibition of the Wnt/β-catenin and NF-κB/cyclooxygenase-2 signaling cascades39. AKBA inhibited the growth of colorectal cancer (CRC) cells and implicated its anti-tumor effects through partial involvement in the up-regulation of specific mRNA pathways and modulation of DNA methylation of various tumor suppressor genes40. Furthermore, oral administration of acetyl-11-keto-beta-boswellic acid (AKBA) derived from the gum resin of the BS showed decrease in tumor volume as well as inhibited the enlargement and metastasis of human CRC tumors in orthotopically implanted tumors in nude mice. These findings revealed that AKBA, could effectively inhibited the enlargement and metastasis of human CRC in vivo through the suppression and down regulation of various cancer-associated biomarkers such as nuclear factor-κB (NF-κB), tumor survival (bcl-2, bcl-xL, inhibitor of apoptosis (IAP-1) and survivin), proliferative (cyclin D1), invasive (intercellular adhesion molecule 1 and matrix metalloproteinase-9) and angiogenic C-X-C (CXC) receptor 4 and vascular endothelial growth factor)41. Intriguingly, it has also been reported that AKBA can down regulate CXCR4 expression in pancreatic cancer cells38.

Subsequently, in in-vitro techniques AKBA significantly suppress VEGF induced phosphorylation of VEGF receptor 2 kinase (KDR/Flk-1) factor responsible for tumour42. A clinical study on malignant brain tumor patients revealed that BS potentially reduces their cerebral edema43.

Anti-diarrhoeal activity: Borrelli et al.11, concluded that BS extract directly inhibits intestinal motility through a mechanism involvement of L-type calcium channels (Fig. 1). Boswellia extract prevents diarrhoea and normalizes intestinal motility in pathophysiological states without slowing the rate of transit in control animals as well as can reduce diarrhoea in patients associated with inflammatory bowel Disease11. However, treatment with this herbal drug is associated to improve a number of parameters related pathology including stool consistency and frequency44,45.

Hepato-protective activity: Inhibition of the LPS induced NO production by water-soluble fraction of the oleo-resin gum of BS in the activated rat peritoneal macrophages is responsible mechanism for hepato-protective and reno-protective activity9. Y et al. reported that hexane extract of BS oleo gum resin showed effective hepato-protective activity with improved histopathological changes in liver at lower dose (Fig. 1). The results were comparable to standard silymarin, a well-known hepato-protective agent12.

Anti-microbial activity: It was established very first time in in-vitro studies by Schmidt et al.46 that Boswellia diterpenes exhibit anti-protozoal activity against Plasmodium falciparum46. BS (dry extracts) when used in combination with other herbal species like Usnea barbata, Rosmarinus officinalis and Salvia officinalis showed antimicrobial activity which might be used for the topical treatment of skin disorders like acne vulgaris and seborrhoic eczema47 (Fig. 1). AKBA showed concentration dependent potential anti-microbial effect against Staphylococcus aureus. Moreover, it has also been observed that AKBA inhibited the formation of biofilms generated by S. aureus and Staphylococcus epidermidis and causes disruption of microbial membrane48.

Wound healing activity: Previously, there were no studies carried for wound healing activity of the oleo-gum- resins obtained from BS. In 2010, Mallik et al.15 formulated a cream using oleo-gum-resins of BS and applied the cream topically on the excision wound surface as single dose at different percentages. Results of this formulation indicated that BS influencing the various phases of wound healing like fibroplasias, collagen synthesis and wound contraction, decrease surface area and increase the tensile strength of the wound resulting in faster healing15 (Fig. 1).

Diuretic activity: Oleo-gum-resin of BS significantly shows diuretic effect27. Phytochemical screening of BS confirmed the presence of saponins and flavonoids. Furosemide induced significant diuresis and electrolytes (Na+ and K+) excretion while plant extracts increased urinary output and electrolytes excretion in a dose-dependent manner. Furthermore, aqueous BS oleo gum extracts administered particularly at the dose of 50 mg kg-1 significantly induced water and electrolyte excretion without any signs of toxicity49 (Fig. 1).

Diuretic activity of the plant extract has been evaluated by increase in urine volume and increased excretion of electrolytes such as sodium (Na+), potassium (K+), chloride (Cl-) and bicarbonate (HCO3-). Whereas, blood urea nitrogen (BUN) levels significantly increased due to dehydration by diuretic effect of the BS, but creatinine level found to be with in the normal value. This study shows that extracts did not show any toxic effect on kidney16.

Analgesic activity: BS non-phenolic fraction obtained from the gum resin has been found to exhibit marked sedative and analgesic effects. A significant analgesic effect observed as evaluated by both hot-wire and mechanical pressure methods. Gum resin OSF BS produced a marked reduction in the spontaneous motor activity and caused apoptosis in rats50. Significant reduction of painful sensation due to tail immersion in warm water and with hot plate method was observed with BS. Further, pain induced using acetic acid, formalin were also abolished by different fractions of BS. Acetic acid induced abdominal constriction and tail immersion methods elucidated peripheral and central activity respectively, while the formalin test investigated both. The hot plate method elucidates peripheral mediated effects of BS17.

Anti-hyperglycemic activity: In an experimental study, it has been revealed that BE could prevent hyperglycemia and inflammation of pancreatic islets in BK+/+ wild type mice treated with 40 mg kg-1 STZ i.p. Authors found that extracts from the gum resin of BS significantly prevented the islet destruction and subsequently hyperglycemia in an animal model of type 1 diabetes. Inhibition of the production of cytokines related might be the underlying mechanisms14 (Fig. 1).

CONCLUSION AND FUTURE PROSPECTIVE

Jesus gifted herb, BS from last decades had experimentally showed various therapeutic effects. It is an important medicinal plant for the treatment of inflammation, ulcer, arthritis, asthma, atherosclerosis, diarrhea, infections, hyperglycemia, wound healing and pain. BS has significantly showed a wide range of medicinal properties and may be used as a promising therapeutic agent for various diseases and serious ailments like cancer. Recent researches have confirmed that BS could play efficient and capable role in eradicating various tumors. This opens a new vista for research for the treatment of diseases which need focus and are at their initial stage of development.

ACKNOWLEDGMENT

We express our gratefulness to Dr. Rajendar Singh Sra, Chairman and Dr. Om Parkash, Secretary, Dr. Senthil Kumar M. Principal, Rajendra Institute of Technology and Sciences, Sirsa, India, for their inspiration and constant support. We express our gratefulness to Dr. Pitchai Balakumar and Ms. Astha for their expertise suggestion and review.

REFERENCES

  • Siddiqui, M.Z., 2011. Boswellia serrata, a potential antiinflammatory agent: An overview. Indian J. Pharm. Sci., 73: 255-261.
    PubMed    Direct Link    


  • Sharma, S., V. Thawani, L. Hingorani, M. Shrivastava, V.R. Bhate and R. Khiyani, 2004. Pharmacokinetic study of 11-Keto beta-Boswellic acid. Phytomedicine, 11: 255-260.
    PubMed    Direct Link    


  • Safayhi, H., B. Rall, E.R. Sailer and H.P.T. Ammon, 1997. Inhibition by boswellic acids of human leukocyte elastase. J. Pharmacol. Exp. Ther., 281: 460-463.
    Direct Link    


  • Gayathri, B., N. Manjula, K.S. Vinaykumar, B.S. Lakshmi and A. Balakrishnan, 2007. Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNF alpha IL-1 beta NO and MAP kinases. Int. Immunopharmacol., 7: 473-482.
    CrossRef    


  • Sharma, A., J. Upadhyay, A. Jain, M.D. Kharya, A. Namdeo and K.R. Mahadik, 2011. Antioxidant activity of aqueous extract of Boswellia serrata. J. Chem. Biol. Phys. Sci., 1: 60-71.
    Direct Link    


  • Singh, S., A. Khajuria, S.C. Taneja, R.K. Johri, J. Singh and G.N. Qazi, 2008. Boswellic acids: A leukotriene inhibitor also effective through topical application in inflammatory disorders. Phytomedicine, 15: 400-407.
    CrossRef    PubMed    Direct Link    


  • Kimmatkar, N., V. Thawani, L. Hingorani and R. Khiyani, 2003. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee-A randomized double blind placebo controlled trial. Phytomedicine, 10: 3-7.
    CrossRef    PubMed    


  • Gupta, I., V. Gupta, A. Parihar, S. Gupta, R. Ludtke, H. Safayhi and H.P. Ammon, 1998. Effects of Boswellia serrata gum resin in patients with bronchial asthma: Results of a double blind, placebo-controlled, 6- week clinical study. Eur. J. Med. Res., 3: 511-514.
    PubMed    


  • Pandey, R.S., B.K. Singh and Y.B. Tripathi, 2005. Extract of gum resins of Boswellia serrata L. inhibits lipopolysaccharide induced nitric oxide production in rat macrophages along with hypolipidemic property. Indian J. Exp. Biol., 43: 509-516.
    PubMed    Direct Link    


  • Huang, M.T., V. Badmaev, Y. Ding, Y. Liu, J.G. Xie and C.T. Ho, 2000. Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid. Biofactors, 13: 225-230.
    PubMed    Direct Link    


  • Borrelli, F., F. Cappasso, R. Cappaso, V. Ascione, G. Aviello, R. Longo and A.A. Izzo, 2006. Effect of Boswellia serrata on intestinal motility in rodent: Inhibition of diarrhea without constipation. Br. J. Pharmacol., 148: 553-560.
    CrossRef    PubMed    


  • Jyothi, Y., J.V. Kamath and M. Asad, 2006. Effect of hexane extract of Boswellia serrata oleo-gum resin on chemically induced liver damage. Pak. J. Pharmaceut. Sci., 19: 129-133.
    Direct Link    


  • Camarda, L., T. Dayton, V. Di Stefano, R. Pitonzo and D. Schillaci, 2007. Chemical composition and antimicrobial activity of some oleogum resin essential oils from Boswellia sp. (Burseraceae). Ann. Chim., 97: 837-844.
    PubMed    Direct Link    


  • Shehata, A.M., L. Quintanilla-Fend, S. Bettio, C.B. Singh and H.P.T. Ammon, 2011. Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE). Phytomedicine, 18: 1037-1044.
    CrossRef    PubMed    Direct Link    


  • Mallik, A., D. Goupale, H. Dhongade and S. Nayak, 2010. Evaluation of Boswellia serrata oleo-gum resin for wound healing activity. Pharm. Lett., 2: 457-463.


  • Ibrahim, M., K.Z. Uddin and M.L. Narasu, 2011. Evaluation of diuretic activity of Boswellia Serrata bark extracts in albino rats. Int. J. Drug Formulation Res., 2: 179-199.
    Direct Link    


  • Sharma, A., S. Bhatia, M.D. Kharya, V. Gajbhiye, N. Ganesh, A.G. Namdeo and K.R. Mahadik, 2010. Anti-inflammatory and analgesic activity of different fractions of Boswellia serrata. Int. J. Phytomed., 2: 94-99.
    Direct Link    


  • Alam, M., H. Khan, L. Samiullah and K.M. Siddique, 2012. A review on phytochemical and pharmacological studies of Kundur (Boswellia serrata Roxb ex Colebr.): A unani drug. J. Applied Pharm. Sci., 2: 148-156.


  • Gerbeth, K., J. Husch, G. Fricker, O. Werz, M. Schubert-Zsilavecz and M. Abdel-Tawab, 2012. In vitro metabolism, permeation and brain availability of six major boswellic acids from Boswellia serrata gum resins. Fitoterapia, 84: 99-106.
    CrossRef    PubMed    Direct Link    


  • Husch, J., J. Bohnet, G. Fricker, C. Skarke and C. Artaria et al., 2012. Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome®) of Boswellia extract. Fitoterapia, 84: 89-98.
    CrossRef    PubMed    Direct Link    


  • Ammon, H.P., 2006. Boswellic acids in chronic inflammatory diseases. Planta Medica, 72: 1100-1116.
    PubMed    Direct Link    


  • Afsar, V., Y.M. Reddy and K.V. Saritha, 2012. In vitro antioxidant activity and anti inflammatory activity of methanolic leaf extract of Boswellia serrata. Int. J. Life Sci. Biotechnol. Pharm. Res., 1: 15-23.
    Direct Link    


  • Zeeyauddin, K., M.L. Narsu, M. Abid and M. Ibrahim, 2011. Evaluation of antiulcer activity of Boswellia serrata bark extracts using aspirin induced ulcer model in albino rats. J. Med. Allied Sci., 1: 14-20.
    Direct Link    


  • Dev, S., 2006. A Selection of Prime Ayurvedic Plant Drugs: Ancient-Modern Concordance. Anamaya Publishers, New Delhi, India


  • Upaganlawar, A. and B. Ghule, 2009. Pharmacological activities of Boswellia serrata Roxb: Mini review. Ethnobotanical Leafl., 13: 766-774.
    Direct Link    


  • Sengupta, K., K.V. Alluri, A.R. Satish, S. Mishra and T. Golakoti et al., 2008. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res. Ther., Vol. 10
    CrossRef    


  • Reddy, G.K., G. Chandrakasan and S.C. Dhar, 1989. Studies on the metabolism of glycosaminoglycans under the influence of new herbal anti-inflammatory agents. Biochem. Pharmacol., 38: 3527-3534.
    CrossRef    PubMed    


  • Ammon, H.P.T., T. Mack, G.B. Singh and H. Safayhi, 1991. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Medica, 57: 203-207.
    CrossRef    PubMed    


  • Houssen, M.E., A. Ragab, A. Mesbah, A.Z. El-Samanoudy, G. Othman, A.F. Moustafa and F.A. Badria, 2010. Natural anti-inflammatory products and leukotriene inhibitors as complementary therapy for bronchial asthma. Clin. Biochem., 43: 887-890.
    CrossRef    


  • Pungle, P., M. Banavalikar, A. Suthar, M. Biyani and S. Mengi, 2003. Immunomodulatory activity of boswellic acids of Boswellia serrata Roxb. Indian J. Exp. Biol., 41: 1460-1462.
    PubMed    Direct Link    


  • Kokkiripati, P.K., L.M. Bhakshu, S. Marri, K. Padmasree, A.T. Row, A.S. Raghavendra and S.D. Tetali, 2011. Gum resin of Boswellia serrata inhibited human monocytic (THP-1) cell activation and platelet aggregation. J. Ethnopharmacol., 137: 893-901.
    CrossRef    PubMed    


  • Shao, Y., C.T. Ho, C.K. Chin, V. Badmaev, W. Ma and M.T. Huang, 1998. Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture. Planta Med., 64: 328-331.
    PubMed    


  • Bhushan, S., A. Kumar, F. Malik, S.S. Andotra and V.K. Sethi et al., 2007. A triterpenediol from Boswellia serrata induces apoptosis through both the intrinsic and extrinsic apoptotic pathways in human leukemia HL-60 cells. Apoptosis, 12: 1911-1926.
    CrossRef    PubMed    


  • Hostanska, K., G. Daum and R. Saller, 2002. Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro. Anticancer Res., 22: 2853-2862.
    PubMed    Direct Link    


  • Park, B., B. Sung, V.R. Yadav, S.G. Cho, M. Liu and B.B. Aggarwal, 2011. Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression. Int. J. Cancer, 129: 23-33.
    CrossRef    PubMed    


  • Bhushan, S., F. Malik, A. Kumar, H.K. Isher, I.P. Kaur, S.C. Taneja and J. Singh, 2009. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrata. Mol. Carcinog., 48: 1093-1108.
    CrossRef    PubMed    


  • Shah, B.A., A. Kumar, P. Gupta, M. Sharma and V.K. Sethi et al., 2007. Cytotoxic and apoptotic activities of novel amino analogues of boswellic acids. Bioorg. Med. Chem. Lett., 17: 6411-6416.
    CrossRef    PubMed    


  • Liu, H.P., Z.H. Gao, S.X. Cui, Y. Wang, B.Y. Li, H.X. Lou and X.J. Qu, 2012. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice. Int. J. Cancer, 132: 2667-2681.
    CrossRef    Direct Link    


  • Liu, M., P. Chen, B. Buchele, S. Dong and D. Huang et al., 2012. A boswellic acid-containing extract attenuates hepatic granuloma in C57BL/6 mice infected with Schistosoma japonicum. Parasitol. Res., 112: 1105-1111.
    CrossRef    Direct Link    


  • Takahashi, M., B. Sung, Y. Shen, K. Hur and A. Link et al., 2012. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family. Carcinogenesis, 33: 2441-2449.
    CrossRef    Direct Link    


  • Yadav, V.R., S. Prasad, B. Sung, J.G. Gelovani, S. Guha, S. Krishnan and B.B. Aggarwal, 2012. Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers. Int. J. Cancer, 130: 2176-2184.
    CrossRef    Direct Link    


  • Pang, X., Z. Yi, X. Zhang, B. Sung and W. Qu et al., 2009. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor recept or 2-mediated angiogenesis. Cancer Res., 69: 5893-5900.
    CrossRef    Direct Link    


  • Kirste, S., M. Treier, S.J. Wehrle, G. Becker and M. Abdel-Tawab et al., 2011. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: A prospective, randomized, placebo-controlled, double-blind pilot trial. Cancer, 117: 3788-3795.
    CrossRef    Direct Link    


  • Gupta, I., A. Parihar, P. Malhotra, S. Gupta, R. Ludtke, H. Safayhi and H.P. Ammon, 2001. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med., 67: 391-395.
    CrossRef    


  • Gerhardt, H., F. Seifert, P. Buvari, H. Vogelsang and R. Repges, 2001. Therapy of active crohn disease with Boswellia serrata extract H 15. Zeitschrift fur Gastroenterol., 39: 11-17.
    CrossRef    Direct Link    


  • Schmidt, T.J., M. Kaiser and R. Brun, 2011. Complete structural assignment of serratol, a cembrane-type diterpene from Boswellia serrata and evaluation of its antiprotozoal activity. Planta Med., 77: 849-850.
    CrossRef    


  • Weckesser, S., K. Engel, B. Simon-Haarhaus, A. Wittmer, K. Pelz and C.M. Schempp, 2007. Screening of plant extracts for antimicrobial activity against bacteria and yeasts with dermatological relevance. Phytomedicine, 14: 508-516.
    CrossRef    PubMed    Direct Link    


  • Raja, A.F., F. Ali, I.A. Khan, A.S. Shawl, D.S. Arora, B.A. Shah and S.C. Taneja, 2011. Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata. Bio. Med. Central Microbiol., Vol. 11.
    CrossRef    


  • Asif, M., M. Atif, S.A.S. Sulaiman, M.A. Hassali, A.A. Shafie, N. Haq and F. Saleem, 2012. Puk1 diuretic activity of aqueous extract of boswellia Serrata Roxb. Oleo gum in normal albino rats. Value Health, 15: A644-A644.
    CrossRef    Direct Link    


  • Menon, M.K. and A. Kar, 1971. Analgesic and psychopharmacological effects of the gum resin of Boswellia serrata. Planta Med., 19: 333-341.
    CrossRef    Direct Link    

  • © Science Alert. All Rights Reserved